1.Obesity and liver fibrosis.
Chinese Journal of Hepatology 2004;12(7):432-432
Fatty Liver
;
etiology
;
pathology
;
Humans
;
Liver Cirrhosis
;
etiology
;
pathology
;
Obesity
;
complications
;
pathology
;
therapy
;
Risk Factors
2.A modified approach to establishing a rat model of liver cancer with concurrent cirrhosis.
Chenjie ZHOU ; Xumeng GONG ; Liquan CAI ; Yan WANG ; Yi GAO
Journal of Southern Medical University 2014;34(4):497-499
OBJECTIVETo establish a modified rat model of liver cancer with concurrent cirrhosis for the study of carcinogenesis characteristics and drug intervention of liver cancer.
METHODSFifty male Wistar rats weighing 100-120 g were randomly divided into normal control group (20 rats) and model group (30 rats). In the model group, the rats were subjected to intraperitoneal injection of 50 mg/kg DEN N-diethylnitrosamine (DEN) twice a week for 4 consecutive weeks, followed then by weekly injections for another 10 weeks. The control rats received injections of 0.1 ml saline in the same manner. At 2, 4, 8, 12, 14, and 18 weeks, 3 rats from each group were sacrificed for assessing tumor formation and liver cirrhosis.
RESULTSLiver cancer with concurrent cirrhosis was induced successfully after 14 weeks of DEN injections. At the 14th week, 3 out of the 5 rats were found to have cirrhosis and LC, and at the 18th week, all the 3 rats examined had cirrhosis and liver cancer. The total carcinogenesis rate in the rats was 75% at 18 weeks with an overall mortality of 33%.
CONCLUSIONThis approach to establishing rat models of liver cancer with concurrent cirrhosis requires simple operation, shortens the time of carcinogenesis, and ensures a high success rate of carcinogenesis and a low mortality rate. The carcinogenesis characteristics in this model are similar to those in human.
Animals ; Liver Cirrhosis, Experimental ; complications ; pathology ; Liver Neoplasms, Experimental ; etiology ; pathology ; Male ; Rats ; Rats, Wistar
4.A Case of Colonic Stricture Induced by Ulcerative Colitis.
The Korean Journal of Gastroenterology 2006;48(5):295-296
No abstract available.
Extracellular Matrix/*metabolism
;
Fibrosis
;
Humans
;
Liver/blood supply/metabolism/*pathology
;
Liver Cirrhosis/etiology/genetics/*metabolism
5.Hepatic Fibrogenesis.
The Korean Journal of Gastroenterology 2006;48(5):297-305
In acute injury, liver recovers completely without any scarring change or complication. However, large portion of liver is changed into fibrotic state by excessive production of extracellular matrix (ECM) under chronic injury. Excessive production of ECM results in hepatic fibrosis and repeated process of hepatic fibrosis progress into liver cirrhosis. Liver cirrhosis is an irreversible and terminal state of chronic liver disease and one of the major causes of death in Korea. To block the progression to liver cirrhosis, various studies in the field of virology and immunology have been proceeded. Recently, studies on the hepatic fibrogenesis have progressed with the development of molecular biology. Hepatic stellate cells (HSC) play a key role in the pathogenesis of hepatic fibrosis by producing ECM. The degree of hepatic fibrosis depends on the proliferation and activation of HSC and increased net production of collagen. Therefore, inhibition of HSC activation is one of the main ways to block the progression of hepatic fibrosis. Many kinds of factors such as oxidative stress, acetaldehyde, ascorbic acid, transforming growth factor-beta (TGF-beta) and carbon tetrachloride (CCl4) have been reported to activate HSC and stimulate collagen gene expression. Although there are no definite and effective antifibrogenic agents, possible candidates are antioxidants, interferon, retinoids such as beta-carotene, flavonoids, renin-angiotensin system inhibitors and peroxisome proliferator activated receptor-gamma (PPAR-gamma) agonists. We tried to evaluate the charateristics of HSC in order to develop agents that inhibit hepatic fibrogenesis.
Extracellular Matrix/*metabolism
;
Fibrosis
;
Humans
;
Liver/blood supply/metabolism/*pathology
;
Liver Cirrhosis/etiology/genetics/*metabolism
7.Acute-on-chronic liver failure.
Clinical and Molecular Hepatology 2013;19(4):349-359
Acute-on-chronic liver failure (ACLF) is an increasingly recognized distinct disease entity encompassing an acute deterioration of liver function in patients with chronic liver disease. Although there are no widely accepted diagnostic criteria for ACLF, the Asia.Pacific Association for the Study of the Liver (APASL) and the American Association for the Study of Liver Disease and the European Association for the Study of the Liver (AASLD/EASL) consensus definitions are commonly used. It is obvious that the APASL and the AASLD/EASL definitions are based on fundamentally different features. Two different definitions in two different parts of the world hamper the comparability of studies. Recently, the EASL-Chronic Liver Failure Consortium proposed new diagnostic criteria for ACLF based on analyses of patients with organ failure. There are areas of uncertainty in defining ACLF, such as heterogeneity of ACLF, ambiguity in qualifying underlying liver disease, argument for infection or sepsis as a precipitating event, etc. Although the exact pathogenesis of ACLF remains to be elucidated, alteration of host response to injury, infection, and unregulated inflammation play important roles. The predisposition, infection/inflammation, response, organ failure (PIRO) concept used for sepsis might be useful in describing the pathophysiology and clinical categories for ACLF. Treatment strategies are limited to organ support but better understanding of the pathophysiology is likely to lead to discovery of novel biomarkers and therapeutic strategies in the future.
Chronic Disease
;
Echocardiography
;
Humans
;
Liver Cirrhosis/complications
;
Liver Failure/diagnosis/etiology/*pathology/prevention & control
;
Liver Failure, Acute/diagnosis/etiology/*pathology/prevention & control
;
Liver Transplantation
;
Sepsis/complications
9.The lymphatic vascular system in liver diseases: its role in ascites formation.
Clinical and Molecular Hepatology 2013;19(2):99-104
The lymphatic system is part of the circulatory system and plays a key role in normal vascular function. Its failure plays a crucial role in the development and maintenance of various diseases including liver diseases. Lymphangiogenesis (the growth of lymphatic vessels) and changes in the properties of lymphatic vessels are associated with pathogenesis of tumor metastases, ascites formation, liver fibrosis/cirrhosis and portal hypertension. Despite its significant role in liver diseases and its importance as a potential therapeutic target for those diseases, the lymphatic vascular system of the liver is poorly understood. Therefore, how the lymphatic vascular system in general and lymphangiogenesis in particular are mechanistically related to the pathogenesis and maintenance of liver diseases are largely unknown. This article summarizes: 1) the lymphatic vascular system; 2) its role in liver tumors, liver fibrosis/cirrhosis and portal hypertension; and 3) its role in ascites formation.
Ascites/*etiology
;
Humans
;
Hypertension, Portal/complications/pathology
;
Liver Cirrhosis/complications/pathology
;
Liver Diseases/complications/*pathology
;
Liver Neoplasms/complications/pathology
;
Lymphangiogenesis
;
Lymphatic Vessels/metabolism/physiopathology
10.Spontaneous rupture of the lateral thoracic artery in patients with liver cirrhosis.
Tae Hee LEE ; Yong Sung PARK ; Dong Jin CHUNG ; Ji Hyung KIM ; Sun Moon KIM ; Euyi Hyeog IM ; Kyu Chan HUH
The Korean Journal of Internal Medicine 2008;23(3):152-155
Bleeding in patients with liver cirrhosis is primarily caused by gastroesophageal varix in association with extensive collateral circulation, portal hypertensive gastropathy, a Mallory-Weiss tear and peptic ulcer disease. The spontaneous rupture of an artery, as a result of coagulopathy, is extremely rare in patients with liver cirrhosis; however, we recently observed a case of a spontaneous rupture of the lateral thoracic artery in a 47 year-old male patient with alcoholic liver cirrhosis. The patient expired despite repeated transcatheter arterial embolization of the lateral thoracic artery and best supportive care. This is, to our knowledge, the first documented case of the spontaneous rupture of the lateral thoracic artery in a patient with liver cirrhosis.
Aneurysm, Dissecting/*etiology
;
Fatal Outcome
;
Humans
;
Liver Cirrhosis/*complications
;
Male
;
Middle Aged
;
Rupture, Spontaneous/*etiology
;
Thoracic Arteries/*pathology
;
Time Factors